INTERVENTIONAL RADIOLOGY / ORIGINAL PAPER
A safe and effective treatment for refractory malignant ascites: the use of pigtail catheters
1
Şehit Prof. Dr. İlhan Varank Training and Research Hospital, Sancaktepe, Turkey
2
Dr. Lütfi Kırdar City Hospital, Kartal, Turkey
Submission date: 2024-08-29
Acceptance date: 2024-10-15
Publication date: 2024-12-10
Corresponding author
Pol J Radiol, 2024; 89: 561-565
KEYWORDS
TOPICS
ABSTRACT
Purpose:
Recurrent malignant ascites is a common and challenging condition in cancer patients, often lacking a standardized treatment protocol. Small-scale studies in the literature have been insufficient to establish a treatment standard. The aim of our study was to investigate the effectiveness and safety of pigtail peritoneal catheter application in the treatment of malignant ascites.
Material and methods:
We conducted a retrospective analysis of patients who had pigtail catheters inserted between January 2017 and December 2022. The study focused on the success rate of the procedure, catheter dwell time, complication rates, and the factors influencing these outcomes.
Results:
A total of 196 patients, 102 of whom were female, with malignant ascites were included in the study. The median age was 65.5 years. The procedure had a 100% success rate, with no procedure-related deaths or major complications. The overall minor complication rate, including bleeding, minor cellulitis, leakage, and blockage, was 52%. Patients with comorbidities experienced statistically significantly more complications (p < 0.05). The median catheter dwell time was 31 days (range: 3-181 days).
Conclusions:
Pigtail peritoneal catheters provide effective and safe minimally invasive fluid drainage for the treatment of malignant ascites. The most critical factors for preventing procedure-related complications and ensuring procedural success include proper indication, correct timing, procedural expertise, and the involvement of well-trained patients and caregivers.
Recurrent malignant ascites is a common and challenging condition in cancer patients, often lacking a standardized treatment protocol. Small-scale studies in the literature have been insufficient to establish a treatment standard. The aim of our study was to investigate the effectiveness and safety of pigtail peritoneal catheter application in the treatment of malignant ascites.
Material and methods:
We conducted a retrospective analysis of patients who had pigtail catheters inserted between January 2017 and December 2022. The study focused on the success rate of the procedure, catheter dwell time, complication rates, and the factors influencing these outcomes.
Results:
A total of 196 patients, 102 of whom were female, with malignant ascites were included in the study. The median age was 65.5 years. The procedure had a 100% success rate, with no procedure-related deaths or major complications. The overall minor complication rate, including bleeding, minor cellulitis, leakage, and blockage, was 52%. Patients with comorbidities experienced statistically significantly more complications (p < 0.05). The median catheter dwell time was 31 days (range: 3-181 days).
Conclusions:
Pigtail peritoneal catheters provide effective and safe minimally invasive fluid drainage for the treatment of malignant ascites. The most critical factors for preventing procedure-related complications and ensuring procedural success include proper indication, correct timing, procedural expertise, and the involvement of well-trained patients and caregivers.
REFERENCES (24)
1.
Hodge C, Badgwell BD. Palliation of malignant ascites. J Surg Oncol 2019; 120: 67-73.
2.
Cavazzoni E, Bugiantella W, Graziosi L, Franceschini MS, Donini A. Malignant ascites: pathophysiology and treatment. Int J Clin Oncol 2013; 18: 1-9.
3.
Becker G, Galandi D, Blum HE. Malignant ascites: systematic review and guideline for treatment. Eur J Cancer 2006; 42: 589-597.
4.
Chan KP, Badiei A, Tan CP, Fitzgerald DB, Stanley C, Fysh ET, et al. Use of indwelling pleural/peritoneal catheter in the management of malignant ascites: a retrospective study of 48 patients. Intern Med J 2020; 50: 705-711.
6.
Maleux G, Indesteege I, Laenen A, Verslype C, Vergote I, Prenen H. Tenckhoff tunneled peritoneal catheter placement in the palliative treatment of malignant ascites: technical results and overall clinical outcome. Radiol Oncol 2016; 50: 197-203.
7.
de Mestier L, Volet J, Scaglia E, Msika S, Kianmanesh R, Bouché O. Is palliative laparoscopic hyperthermic intraperitoneal chemotherapy effective in patients with malignant hemorrhagic ascites? Case Rep Gastroenterol 2012; 6: 166-170.
8.
Petzold G, Bremer SC, Heuschert FC, Treiber H, Ellenrieder V, Kunsch S, et al. Tunnelled peritoneal catheter for malignant ascites – an open-label, prospective, observational trial. Cancers 2021; 13: 2926. DOI: 10.3390/cancers13122926.
9.
Knight JA, Thompson SM, Fleming CJ, Bendel EC, Neisen MJ, Neidert NB, et al. Safety and effectiveness of palliative tunneled peritoneal drainage catheters in the management of refractory malignant and non-malignant ascites. Cardiovasc Intervent Radiol 2018; 41: 753-761.
10.
Lungren MP, Kim CY, Stewart JK, Smith TP, Miller MJ. Tunneled peritoneal drainage catheter placement for refractory ascites: single-center experience in 188 patients. J Vasc Interv Radiol 2013; 24: 1303-1308.
11.
O’Neill M, Weissleder R, Gervais DA, Hahn PF, Mueller PR. Tunneled peritoneal catheter placement under sonographic and fluoroscopic guidance in the palliative treatment of malignant ascites. Am J Roentgenol 2001; 177: 615-618.
12.
Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 2003; 14 (9 Pt 2): S199-S202.
13.
Türk Y, Devecioğlu İ, Yıldızhan İ, Arslan BC, Arıbaş BK. Tunneled uncuffed pigtail drainage catheter placement in patients with refractory ascites or pleural effusion: a single-center experience. Cardiovasc Intervent Radiol 2022; 45: 1735-1741.
14.
White MA, Agle SC, Padia RK, Zervos EE. Denver peritoneovenous shunts for the management of malignant ascites: a review of the literature in the post LeVeen Era. Am Surg 2011; 77: 1070-1075.
15.
Tamagawa H, Aoyama T, Inoue H, Fujikawa H, Sawazaki S, Numata M, et al. Therapeutic results of Denver percutaneous peritoneovenous shunt in cancer patients with malignant ascites. J Cancer Res Ther 2020; 16 (Suppl 1): S95-S98.
16.
Schumacher DL, Saclarides TJ, Staren ED. Peritoneovenous shunts for palliation of the patient with malignant ascites. Ann Surg Oncol 1994; 1: 378-381.
17.
Seah DS, Wilcock A, Chang S, Sousa MS, Sinnarajah A, Teoh CO, et al. Paracentesis for cancer-related ascites in palliative care: an international, prospective cohort study. Palliat Med 2022; 36: 1408-1417.
18.
Wu X, Keller EJ, Rabei R, Rockwell H, Beeson S, Heller M, et al. Cost-effectiveness of tunneled peritoneal catheters versus repeat paracenteses for recurrent ascites in gynecologic malignancies. Gynecol Oncol 2022; 164: 639-644.
19.
Bohn KA, Ray Jr CE. Repeat large-volume paracentesis versus tunneled peritoneal catheter placement for malignant ascites: a cost-minimization study. Am J Roentgenol 2015; 205: 1126-1134.
20.
Wu X, Rabei R, Keller EJ, King B, Kothary N, Kohi M, et al. Tunneled peritoneal catheter vs repeated paracenteses for recurrent ascites: a cost-effectiveness analysis. Cardiovasc Intervent Radiol 2022; 45: 972-982.
21.
Kou F, Gong J, Li Y, Li J, Zhang X, Li J, et al. Phase I study of intraperitoneal bevacizumab for treating refractory malignant ascites. J Int Med Res 2021; 49: 0300060520986664. DOI: 10.1177/0300060520986664.
22.
Akinci D, Erol B, Ciftci TT, Akhan O. Radiologically placed tunneled peritoneal catheter in palliation of malignant ascites. Eur J Radiol 2011; 80: 265-268.
23.
Murray FR, Gnehm F, Schindler V, Morell B, Gubler C, Kretsch-mer EM, et al. Permanent tunneled drainage of ascites in palliative patients: timing needs evaluation. J Palliat Med 2022; 25: 1132-1135.
24.
Narayanan G, Pezeshkmehr A, Venkat S, Guerrero G, Barbery K. Safety and efficacy of the PleurX catheter for the treatment of malignant ascites. J Palliat Med 2014; 17: 906-912.
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
